For those at #FENS - an exciting poster worthy of your time

Ribosome-Associated Vesicles promote activity-dependent local translation biorxiv.org/content/10.110…

Our circadian rhythm and how its disruption is linked to metabolic syndrome, obesity, Type 2 diabetes and cardiovascular disease. A first-rate review Journal of Clinical Investigation jci.org/articles/view/… Lauren Schrader, MPH Kristen Malecki

Characterizing the Spatial Distribution of Dendritic RNA at Single Molecule Resolution biorxiv.org/cgi/content/sh… #biorxiv_neursci

In a new study published in Nature, some mice received a drug that eliminates interleukin-11 from the body, a protein that has been found to become more active as we age. Their lifespans were increased by 20-25%, and they had fewer cancers and were less frail. #AnimalResearch

snoRNAs in making “snoman” ribosomes dlvr.it/TCHkcm

Will you be joining us this December 6-10 in Los Angeles for #AES2024?

We had a blast in our mRNA Translation in Plasticity symposium today. But it's not done, don't miss the excellent symposium on Neuronal Translation tomorrow! 🔥

Cells keep tabs on RNA production in the nucleus to control the levels of RNA degradation in the cytoplasm. elifesciences.org/digests/90766/…

Nature research paper: Neuronal sequences in population bursts encode information in human cortex go.nature.com/48c4YRP

RNA granules in flux: dynamics to balance physiology and pathology — a Review by Michael A. Kiebler & Karl E. Bauer go.nature.com/3UCa0Se

We’re delighted to announce a new partnership between Oxford StemTech, King's College London, and MaxWell Biosystems, funded by Innosuisse. Many patients with #epilepsy struggle with limited treatment options to manage their seizures effectively. To address this, our collaboration

GPCR drug discovery: new agents, targets and indications nature.com/articles/s4157… This new review analyses drug discovery trends for GPCRs, covering compounds, targets and indications that have reached regulatory approval or that are being investigated in clinical trials

The SEND system is already failing so many children. Cutting funding is not the answer! 24% of children with SEND have speech and language challenges – ensuring they get the right support is key to fixing this broken system🤝 theguardian.com/education/2025…

NOW IN #PAIN: @UTDpainlab et al. find that baseline epigenomic sex differences in the human dorsal root ganglia drive distinct transcriptional programs that likely contribute to sexual dimorphism in pain. bit.ly/41gonza

Amazing work! Congratulations Yichen Q and Lignani Lab ! Very exciting and a huge advance for gene therapy for neurological diseases

What an amazing tool! Incredible work Neural Computation Lab

Yet another benefit of sleep!